vs
Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Sunshine Biopharma Inc. is the larger business by last-quarter revenue ($8.6M vs $6.0M, roughly 1.4× CHICAGO RIVET & MACHINE CO). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -25.0%, a 5.6% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -10.6%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-1.6M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -12.7%).
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
CVR vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.0M | $8.6M |
| Net Profit | $-1.2M | $-2.1M |
| Gross Margin | 2.7% | 35.3% |
| Operating Margin | -15.3% | -20.9% |
| Net Margin | -19.3% | -25.0% |
| Revenue YoY | 45.9% | -10.6% |
| Net Profit YoY | 68.0% | 0.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.0M | $8.6M | ||
| Q3 25 | $7.4M | $9.4M | ||
| Q2 25 | $7.3M | $9.4M | ||
| Q1 25 | $7.2M | $8.9M | ||
| Q4 24 | $4.1M | $9.6M | ||
| Q3 24 | $7.0M | $8.4M | ||
| Q2 24 | $8.1M | $9.3M | ||
| Q1 24 | $7.9M | $7.5M |
| Q4 25 | $-1.2M | $-2.1M | ||
| Q3 25 | $67.6K | $-883.8K | ||
| Q2 25 | $-395.0K | $-1.8M | ||
| Q1 25 | $401.0K | $-1.2M | ||
| Q4 24 | $-3.6M | $-2.2M | ||
| Q3 24 | $-1.4M | $-1.2M | ||
| Q2 24 | $142.1K | $-494.3K | ||
| Q1 24 | $-698.0K | $-1.3M |
| Q4 25 | 2.7% | 35.3% | ||
| Q3 25 | 18.1% | 32.6% | ||
| Q2 25 | 13.4% | 36.4% | ||
| Q1 25 | 22.9% | 30.7% | ||
| Q4 24 | -43.7% | 32.2% | ||
| Q3 24 | 10.0% | 34.0% | ||
| Q2 24 | 17.6% | 25.3% | ||
| Q1 24 | 9.5% | 31.2% |
| Q4 25 | -15.3% | -20.9% | ||
| Q3 25 | 0.9% | -11.5% | ||
| Q2 25 | -5.7% | -21.8% | ||
| Q1 25 | 1.0% | -14.6% | ||
| Q4 24 | -86.4% | -21.7% | ||
| Q3 24 | -11.8% | -13.1% | ||
| Q2 24 | 1.3% | -13.6% | ||
| Q1 24 | -11.5% | -17.9% |
| Q4 25 | -19.3% | -25.0% | ||
| Q3 25 | 0.9% | -9.4% | ||
| Q2 25 | -5.4% | -18.8% | ||
| Q1 25 | 5.5% | -13.3% | ||
| Q4 24 | -88.0% | -22.5% | ||
| Q3 24 | -20.8% | -14.2% | ||
| Q2 24 | 1.8% | -5.3% | ||
| Q1 24 | -8.9% | -17.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.82 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $49.77 | ||
| Q3 24 | — | $-11.61 | ||
| Q2 24 | — | $-43.48 | ||
| Q1 24 | — | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.8M | $23.0M |
| Total Assets | $23.3M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $765.6K | — | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.8M | $23.0M | ||
| Q3 25 | $20.0M | $24.2M | ||
| Q2 25 | $20.0M | $25.7M | ||
| Q1 25 | $20.4M | $22.7M | ||
| Q4 24 | $20.0M | $23.5M | ||
| Q3 24 | $23.7M | $25.0M | ||
| Q2 24 | $25.2M | $23.5M | ||
| Q1 24 | $25.2M | $24.8M |
| Q4 25 | $23.3M | $30.1M | ||
| Q3 25 | $24.0M | $31.5M | ||
| Q2 25 | $23.6M | $32.0M | ||
| Q1 25 | $24.1M | $29.2M | ||
| Q4 24 | $23.4M | $30.6M | ||
| Q3 24 | $26.4M | $30.1M | ||
| Q2 24 | $27.3M | $29.3M | ||
| Q1 24 | $27.8M | $31.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $116.4K | $-1.6M |
| Free Cash FlowOCF − Capex | $24.3K | $-1.6M |
| FCF MarginFCF / Revenue | 0.4% | -18.9% |
| Capex IntensityCapex / Revenue | 1.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.6M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.4K | $-1.6M | ||
| Q3 25 | $638.0K | $-727.8K | ||
| Q2 25 | $28.2K | $-1.3M | ||
| Q1 25 | $-2.0M | $-1.7M | ||
| Q4 24 | $-60.1K | $-3.4M | ||
| Q3 24 | $-58.2K | $-1.4M | ||
| Q2 24 | $363.5K | $-4.6M | ||
| Q1 24 | $-398.8K | $-3.2M |
| Q4 25 | $24.3K | $-1.6M | ||
| Q3 25 | $492.1K | $-735.8K | ||
| Q2 25 | $-22.8K | $-1.4M | ||
| Q1 25 | $-2.1M | $-1.7M | ||
| Q4 24 | $-118.1K | $-3.5M | ||
| Q3 24 | $-368.9K | $-1.9M | ||
| Q2 24 | $58.0K | $-5.6M | ||
| Q1 24 | $-491.8K | $-3.2M |
| Q4 25 | 0.4% | -18.9% | ||
| Q3 25 | 6.7% | -7.8% | ||
| Q2 25 | -0.3% | -15.2% | ||
| Q1 25 | -28.3% | -19.3% | ||
| Q4 24 | -2.9% | -36.6% | ||
| Q3 24 | -5.3% | -22.2% | ||
| Q2 24 | 0.7% | -59.7% | ||
| Q1 24 | -6.3% | -43.1% |
| Q4 25 | 1.5% | 0.0% | ||
| Q3 25 | 2.0% | 0.1% | ||
| Q2 25 | 0.7% | 1.7% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 1.4% | 1.1% | ||
| Q3 24 | 4.5% | 6.1% | ||
| Q2 24 | 3.8% | 10.5% | ||
| Q1 24 | 1.2% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
SBFM
Segment breakdown not available.
